Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 3, 2014BloodOpen Access

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEdgardo R. Parrilla CastellarDuke Medical Center
Elaine S. Jaffe
Elaine S. JaffeBoston UniversityJSJonathan SaidUniversity of California, Los Angeles

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Castellar et al. (2014) studied this question.

synapsesocial.com/papers/6a120bfcea48cb855a341f77https://doi.org/10.1182/blood-2014-04-571091
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity1995 · 389 citations
  2. 2ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project2008 · 867 citations
  3. 3ALK‐negative anaplastic large‐cell lymphoma demonstrates similar poor prognosis to peripheral T‐cell lymphoma, unspecified2003 · 106 citations